Myroides odoratus polymicrobial cellulitis complicated by sepsis and acute kidney injury in an adolescent with focal segmental glomerulosclerosis: a case report

In the human body, the immune system acts as a constant, vigilant defense force, patrolling the skin and tissues to neutralize invaders before they can cause harm. For most people, a simple cut or scrape is a minor event, quickly sealed off and cleaned by white blood cells. However, when the body's defenses are weakened, the landscape changes entirely. Certain medical conditions, such as nephrotic syndrome, strip the body of essential proteins that help fight infection, while treatments like corticosteroids, though necessary to manage the underlying disease, further dampen the immune response. In this vulnerable state, the skin becomes a fragile barrier, and the environment that usually keeps bacteria in check can turn into a breeding ground for organisms that are rarely seen in healthy individuals. Among these rare invaders are bacteria that live in soil and water, which typically do not infect humans but can seize the opportunity when the body's guard is down. These organisms are often difficult to treat because they carry built-in defenses against many common medicines, making the choice of the right drug a critical and often urgent challenge for doctors.

This story begins with a seventeen-year-old boy who had recently been diagnosed with a kidney condition called focal segmental glomerulosclerosis. This disease causes the kidneys to leak large amounts of protein into the urine, leading to severe swelling throughout the body. To treat this, he was placed on a high dose of prednisolone, a powerful steroid that calms the immune system's attack on the kidneys. One month into this therapy, the boy returned to the hospital with a severe infection. Both of his lower legs were swollen, red, and covered in fluid-filled blisters that were leaking pus. He had a fever and was clearly very ill. Because his immune system was suppressed by the medication, the medical team immediately suspected a serious bacterial infection and started him on standard antibiotics designed to kill the most common germs found in skin infections.

Despite the treatment, the boy's condition did not improve. Within two days, he became worse, developing signs of sepsis, a life-threatening reaction to infection that spreads through the bloodstream. His kidneys, already struggling, began to fail rapidly, with waste products building up in his blood to dangerous levels. The medical team realized that the initial antibiotics were not working and escalated the treatment to stronger, broader-spectrum drugs. They also began a search for the specific culprit behind the infection by testing the fluid from the boy's wounds. While waiting for the results, the boy required dialysis, a machine that temporarily took over the work of his kidneys to filter his blood, as his own organs could no longer cope.

On the fourth day of his hospital stay, the laboratory results arrived, revealing a complex and dangerous situation. The infection was not caused by a single germ, but by two different bacteria growing together. One was a common type known as Klebsiella pneumoniae, but the other was a much rarer organism called Myroides odoratus. This second bacterium is an environmental germ found in soil and water that is not normally part of the human body. It is notorious for being resistant to almost every standard antibiotic doctors use, including penicillins, cephalosporins, and even the strongest drugs like carbapenems. In this specific case, the Myroides bacteria was found to be resistant to every drug tested except for one: minocycline. The other bacterium, Klebsiella, was also resistant to the initial drugs the doctors had tried, but it could be killed by a different class of antibiotics.

Armed with this precise information, the medical team switched the boy's treatment to a targeted approach. They stopped the broad-spectrum drugs and began administering minocycline to kill the Myroides and ceftazidime to handle the Klebsiella. This change in strategy marked the turning point. By the tenth day, the boy's fever had broken, and his body began to recover. Over the next two weeks, his kidney function returned to normal, his blood counts stabilized, and the wounds on his legs healed completely. When the doctors tested the wound fluid again at the end of his treatment, no bacteria were found. The boy was discharged after twenty-one days of antibiotics, having survived a severe, multi-drug-resistant infection that had nearly overwhelmed his system.

This case is significant because it highlights a specific and dangerous gap in medical knowledge regarding patients with kidney disease. While doctors know that these patients are prone to infections, this report describes the first known instance where Myroides odoratus caused a severe skin infection in someone with nephrotic syndrome. The infection was complicated by the fact that the bacteria were resistant to almost all standard treatments, a trait that is becoming more common in this type of organism. The success of the treatment relied entirely on identifying the specific bacteria and its unique weakness. Without the culture results that identified the need for minocycline, the boy likely would not have recovered, as the standard drugs used for skin infections have no effect on this particular germ.

The report also underscores the difficulty of treating infections in immunocompromised patients. The boy's condition was a mix of factors: the underlying kidney disease, the loss of protective proteins, the swelling of his tissues, and the medication that lowered his immune defenses. These factors combined to create an environment where a rare, soil-dwelling bacterium could take hold and multiply. The case demonstrates that when a patient with a weakened immune system does not respond to initial treatment, doctors must look beyond the usual suspects. They need to be prepared for rare organisms that carry their own built-in shields against medicine. In this instance, the ability to quickly identify the bacteria and switch to the single drug that could kill it saved the patient's life. It serves as a reminder that in the world of infectious disease, the right answer often lies not in guessing, but in knowing exactly what is fighting back.